EPN — Epsilon Healthcare Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.66 | 4.79 | 6.95 | 5.5 | 7.11 |
Cost of Revenue | |||||
Gross Profit | 0.679 | 1.07 | 2.34 | 1.92 | 1.24 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11.4 | 16.6 | 17.7 | 17.2 | 20.1 |
Operating Profit | -8.78 | -11.8 | -10.8 | -11.7 | -13 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.61 | -11.7 | -10.5 | -10.1 | -13.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.61 | -11.7 | -10.5 | -9.24 | -13.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.61 | -11.7 | -10.5 | -9.24 | -13.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.61 | -11.7 | -10.5 | -9.24 | -13.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.06 | -0.073 | -0.066 | -0.039 | -0.026 |